In order to evaluate the underlying mechanism of action of the dual mTOR inhibitor PP242, the LS174T xenograft mouse model was treated with PP242 for 3 weeks, and plasma and tumor samples were analyzed via metabolomics and lipidomics approaches. Here, MTOR is linked to neoplasm.